Learn more

ANDROSCIENCE CORP

Overview
  • Total Patents
    54
  • GoodIP Patent Rank
    203,236
About

ANDROSCIENCE CORP has a total of 54 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Canada, China and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are BIO PHARM SOLUTIONS CO LTD, BIO-PHARM SOLUTIONS CO LTD and SMITHKLINE BEECHAM PHARMA GMBH.

Patent filings per year

Chart showing ANDROSCIENCE CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Shi Qian 39
#2 Wang Hui-Kang 35
#3 Su Ching-Yuan 29
#4 Shih Charles C Y 21
#5 Shih Charles 16
#6 Shih Charles C-Y 11
#7 Kawashima Toshiyuki 7
#8 Kitamura Toshio 7
#9 Wang Hui Kang 6
#10 Vance John Robert 3

Latest patents

Publication Filing date Title
US2015190351A1 Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyI)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
CN110279680A A kind of medical composition and its use
AU2011292144A1 1,5-diphenyl-penta-1,4-dien-3-one compounds
TW201026310A Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss
AU2008243284A1 Novel curcumin analogues and uses thereof
TW201018458A Compound with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
AU2008282749A1 Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss
CA2674780A1 Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
MX2007002583A Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof.
NZ548670A Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof
TW200609351A Methods and compositions for degradation of transcription factors and uses thereof
CA2501901A1 Anticancer compounds